- Research Grants
graduation at Biomedicina from Centro Universitário Lusíada (2006), master's at Ciências (Departamento de Farmacologia) from Universidade Federal de São Paulo (2009) and doctorate at Ciências (Departamento de Farmacologia) from Universidade Federal de São Paulo (2013). Has experience in Medicine (Source: Lattes Curriculum)
|News published in Agência FAPESP Newsletter about the researcher|
|Biomarker panel can guide treatment of brain cancer|
Glioma is a heterogeneous group of tumors whose aetiology, histomorphologic features, molecular signatures, clinical behavior, response to therapy, and prognosis are variable. Glioma accounts for around eighty percent of all primary brain cancers. Some low-grade gliomas tend to progress to lesions with higher grades of malignancy. Glioblastoma multiforme (GBM), considered a high grade (...
Harmful and damaging effects on global chromatin and epigenomic pattern, gene expression, and cellular phenotype has been known to be associated with cancer. The post genome-wide association studies era offers a blueprint for investigating genomics, epigenomics, and transcriptomics information together, providing us an exciting opportunity to enlighten how complex diseases develop at th...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
|Data from Web of Science|